文献速递血栓与止血

Fcγ受体基因多态性对儿童暂时性与慢性免疫性血小板减少症的差异化影响

Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms.
PubMed 文献 · Blood Adv · 2019-01-01

该研究对180例新诊断儿童ITP、22例慢性ITP及180例健康对照进行FCGR2/3位点基因分型,并在TIKI trial中随访1年。FCGR2C*ORF与暂时性ITP易感相关(OR 4.7),FCGR2C/FCGR3B缺失与慢性ITP相关(OR 6.2),提示FCGR2/3基因分型可能有助于预后判断和治疗决策。

要点

  • FCGR2C*ORF与暂时性ITP易感相关,OR为4.7(95%CI 1.9-14.3)。
  • FCGR2C/FCGR3B缺失与慢性ITP相关,OR为6.2(95%CI 1.8-24.7)。
  • FCGR2C*ORF、FCGR2A*27W和FCGR2B启动子变异2B.4在暂时性ITP中过表达,慢性ITP中无此现象。

核心结论

  • 暂时性与慢性儿童ITP的易感性受FCGR2/3基因多态性变异的不同影响。
  • 数据提示FCGR2/3位点基因分型可能有助于新诊断儿童ITP的预后判断和治疗决策指导。

研究设计与样本

  • 对180例新诊断ITP儿童、22例慢性ITP儿童和180例健康对照儿童,采用多重连接依赖探针扩增法进行FCGR2/3位点基因分型。
  • 新诊断ITP儿童被随机分配接受单次IVIg或观察,随访1年(TIKI trial)。
  • 暂时性ITP定义为诊断后3个月完全恢复(≥100×10^9/L),包括自限性疾病/IVIg应答者和慢性ITP定义为12个月时未完全恢复。

主要发现

  • ITP易感性、自发恢复和IVIg应答与FCGR2C*ORF、FCGR2A*27W和FCGR2B启动子变异2B.4相关。
  • 这些变异在暂时性ITP患者(N=131)中过表达,但在慢性ITP患者(N=43)中无过表达。
  • FCGR2C*ORF predisposed to transient ITP with an odds ratio of 4.7 (95%CI 1.9-14.3)。
  • 慢性ITP与FCGR2C/FCGR3B缺失(拷贝数区域1)相关,OR为6.2(95%CI 1.8-24.7)。

关键数值与推荐

  • 暂时性ITP定义为诊断后3个月完全恢复(≥100×10^9/L)。
  • 慢性ITP定义为12个月时未完全恢复。
  • FCGR2C*ORF与暂时性ITP易感相关,OR 4.7(95%CI 1.9-14.3)。
  • FCGR2C/FCGR3B缺失与慢性ITP相关,OR 6.2(95%CI 1.8-24.7)。

临床怎么用

  • FCGR2/3位点基因分型可能有助于新诊断儿童ITP的预后判断和治疗决策指导。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In childhood immune thrombocytopenia (ITP), anti-platelet autoantibodies mediate platelet clearance through Fc-γ receptor (FcγR)-bearing phagocytes. In 75% to 90% of patients, the disease has a transient, self-limiting character. Here we characterized how polymorphisms of FcγR genes affect disease susceptibility, response to intravenous immunoglobulin (IVIg) treatment, and long-term recovery from childhood ITP. Genotyping of the FCGR2/3 locus was performed in 180 children with newly diagnosed ITP, 22 children with chronic ITP, and 180 healthy control children by multiplex ligation-dependent probe amplification. Children with newly diagnosed ITP were randomly assigned to a single administration of IVIg or observation, and followed for 1 year (Treatment With or Without IVIg for Kids With ITP [TIKI] trial). We defined transient ITP as a complete recovery (≥100 × 109/L) 3 months after diagnosis, including both self-limiting disease/IVIg responders and chronic ITP as absence of a complete recovery at 12 months. ITP susceptibility, as well as spontaneous recovery and response to IVIg, was associated with the genetic variants FCGR2C*ORF and FCGR2A*27W and the FCGR2B promoter variant 2B.4. These variants were overrepresented in patients with transient (N = 131), but not chronic (N = 43), disease. The presence of FCGR2C*ORF predisposed to transient ITP with an odds ratio of 4.7 (95% confidence interval, 1.9-14.3). Chronic ITP was associated with a deletion of FCGR2C/FCGR3B (copy number region 1) with an odds ratio of 6.2 (95% confidence interval, 1.8-24.7). Taken together, susceptibility to transient and chronic ITP is distinctly affected by polymorphic variants of FCGR2/3 genes. Our data suggest that genotyping of the FCGR2/3 locus may be useful for prognosis and guidance of treatment decisions in newly diagnosed childhood ITP.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Schmidt DE, Heitink-Pollé KMJ, Laarhoven AG, et al. Transient and chronic childhood immune thrombocytopenia are distinctly affected by Fc-γ receptor polymorphisms. Blood Adv. 2019. PMID: 31270082. doi:10.1182/bloodadvances.2019000068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。